We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04840199
Brief Title: A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes. (ELICIT)

First Submitted : April 7, 2021
First Submitted that Met QC Criteria : April 7, 2021
First Posted : April 9, 2021

Last Update Submitted that Met QC Criteria : January 3, 2023
Last Update Posted : January 5, 2023